What is the Role of HTA for Biosimilars?
![396 - 2014 Role-of-HTA-for-Biosimilars-Mestre-Ferrandiz-Jul2015](https://www.ohe.org/wp-content/uploads/2015/07/396-2014-Role-of-HTA-for-Biosimilars-Mestre-Ferrandiz-Jul2015.jpg)
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.